Literature DB >> 19378419

Signal transduction involved in CTGF-induced production of chemokines in mesangial cells.

Sheng-Hua Wu1, Chao Lu, Ling Dong, Zi-Qing Chen.   

Abstract

OBJECTIVE AND
DESIGN: This study investigates the regulatory role of connective tissue growth factor (CTGF) on production of fractalkine, monocyte-chemoattractant protein-1 (MCP-1) and regulated on activation, normal T cell expressed and secreted (RANTES) in human mesangial cells, and explore the mechanisms of CTGF action.
METHODS: Cultured human mesangial cells were treated with CTGF. Expressions of mRNA and proteins of fractalkine, MCP-1 and RANTES were analyzed by real-time polymerase chain reaction (PCR) and by enzyme-linked immunosorbent assay, respectively. Expressions of phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2), phosphoinositide 3-kinase (PI3-K) and protein kinase B (PKB) were assessed by Western blotting. Activities of nuclear factor-KB (NF-KB) were determined by NF-kappaB luciferase reporter assay.
RESULTS: CTGF enhanced the mRNA expressions and protein release of fractalkine, MCP-1 and RANTES, and the expressions of phosphorylated ERK1/2, PI3-K and PKB, and activities of NF-KB. Blockade of ERK1/2 inhibited the CTGF-induced expression ofphosphorylated ERK1/2 and NF-kappaB, and partially decreased the expressions of the above chemokines. PI3-K blockade downregulated the CTGF-stimulated expressions of phosphorylated PI3-K, PKB and NF-kappaB but not phosphorylated ERK1/2, partially decreased the expressions of the above chemokines. NF-kappaB blockade abrogated the CTGF-activated NF-kappaB and partially decreased the expressions of the above chemokines. Soluble heparin and K252a, an inhibitor of Trk, blocked CTGF-induced production of the above chemokines and the activation of the above signaling proteins.
CONCLUSION: These results demonstrated that CTGF induces production of fractalkine, MCP-1 and RANTES via ERK1/2 and PI3-K/PKB/NF-kappaB-dependent signal pathway mediated by cell surface heparin sulfate proteoglycans and the tyrosine kinase receptor TrkA in human mesangial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19378419     DOI: 10.1080/08977190802227828

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  14 in total

Review 1.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

2.  The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.

Authors:  Raúl R Rodrigues-Diez; Ana Belen Garcia-Redondo; Macarena Orejudo; Raquel Rodrigues-Diez; Ana Maria Briones; Enrique Bosch-Panadero; Gyorgy Kery; Janos Pato; Alberto Ortiz; Mercedes Salaices; Jesus Egido; Marta Ruiz-Ortega
Journal:  Antioxid Redox Signal       Date:  2015-01-01       Impact factor: 8.401

3.  Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII.

Authors:  Rima Khankan; Noelynn Oliver; Shikun He; Stephen J Ryan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-07       Impact factor: 4.799

4.  Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

Authors:  Roger M Mason
Journal:  J Cell Commun Signal       Date:  2009-02-14       Impact factor: 5.782

5.  Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.

Authors:  A J Booth; K Csencsits-Smith; S C Wood; G Lu; K E Lipson; D K Bishop
Journal:  Am J Transplant       Date:  2009-09-25       Impact factor: 8.086

6.  Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.

Authors:  Roger M Mason
Journal:  Int J Exp Pathol       Date:  2012-10-30       Impact factor: 1.925

7.  BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses.

Authors:  Kira Young; Eric Tweedie; Barbara Conley; Jacquelyn Ames; MaryLynn FitzSimons; Peter Brooks; Lucy Liaw; Calvin P H Vary
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

8.  Hyperglycemia causes renal cell damage via CCN2-induced activation of the TrkA receptor: implications for diabetic nephropathy.

Authors:  Maria Fragiadaki; Nicola Hill; Reiko Hewitt; George Bou-Gharios; Terence Cook; Frederick W Tam; Jan Domin; Roger M Mason
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

9.  Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.

Authors:  Zhen-Zhou Zhang; Qian-Hui Shang; Hai-Yan Jin; Bei Song; Gavin Y Oudit; Lin Lu; Tong Zhou; Ying-Le Xu; Ping-Jin Gao; Ding-Liang Zhu; Josef M Penninger; Jiu-Chang Zhong
Journal:  J Transl Med       Date:  2013-09-25       Impact factor: 5.531

Review 10.  CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?

Authors:  Qingan Jia; Qiongzhu Dong; Lunxiu Qin
Journal:  Oncotarget       Date:  2016-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.